1563-86-6 Usage
General Description
N-acetyl-N-butylacetamide is an organic compound that belongs to the class of amides. It is derived from acetic acid and butylamine through a process of acetylation. This chemical is commonly used as a plasticizer in various industries, particularly in the production of adhesives, sealants, and coatings. It is also used as a solvent and as a viscosity-adjusting agent in different formulations. N-acetyl-N-butylacetamide is known for its ability to improve the flexibility, durability, and performance of plastic and rubber materials. However, it is important to handle this compound with caution, as it may present some health hazards if not properly managed.
Check Digit Verification of cas no
The CAS Registry Mumber 1563-86-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,5,6 and 3 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1563-86:
(6*1)+(5*5)+(4*6)+(3*3)+(2*8)+(1*6)=86
86 % 10 = 6
So 1563-86-6 is a valid CAS Registry Number.
InChI:InChI=1/C8H15NO2/c1-4-5-6-9(7(2)10)8(3)11/h4-6H2,1-3H3
1563-86-6Relevant articles and documents
Comparison of the hypolipidemic activity of cyclic vs. acyclic imides
Voorstad,Chapman,Cocolas,Wyrick,Hall
, p. 9 - 12 (2007/10/02)
Two series of nitrogen-substituted cyclic and acyclic imides were examined for hypolipidemic activity in mice after dosing for 16 days at a dose of 20 mg/kg per day. The hypolipidemic activity of the unsubstituted, N-butyl, N-3-oxobutyl, and N-2-carboxyethyl derivatives of diacetimide and succinimide were compared as well as the unsubstituted and N-substituted dibenzimide and diphenimide. It was shown that an imide functionally incorporated into a ring was not necessary for hypocholesterolemic activity. Good hypocholesterolemic activity was observed in both series of acyclic and cyclic imides. However, a cyclic imido structure was a necessary requirement for good hypotriglyceridemic activity. A decrease in hypotriglyceridemic activity was noted when comparing the cyclic imides to their respective acyclic congeners.
